# A Long-term Safety Study of Once-daily Travatan

> **NCT00051168** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 502 (actual)

## Conditions studied

- Glaucoma, Open-angle
- Ocular Hypertension

## Interventions

- **DRUG:** Travatan

## Key facts

- **NCT ID:** NCT00051168
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 502 (ACTUAL)
- **Last updated:** 2011-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00051168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00051168, "A Long-term Safety Study of Once-daily Travatan". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00051168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*